Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3499 | 1971 | 36.1 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
261 | 3 | HELICOBACTER PYLORI//GASTROENTEROLOGY & HEPATOLOGY//HELICOBACTER | 44585 |
196 | 2 | HELICOBACTER PYLORI//HELICOBACTER//GASTRITIS | 21432 |
3499 | 1 | ATROPHIC GASTRITIS//PEPSINOGEN//INTESTINAL METAPLASIA | 1971 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ATROPHIC GASTRITIS | authKW | 1369202 | 10% | 46% | 192 |
2 | PEPSINOGEN | authKW | 971706 | 8% | 41% | 154 |
3 | INTESTINAL METAPLASIA | authKW | 833465 | 11% | 25% | 212 |
4 | HELICOBACTER PYLORI | authKW | 695819 | 36% | 6% | 705 |
5 | PEPSINOGEN I | authKW | 298422 | 2% | 57% | 34 |
6 | GASTRIC CANCER | authKW | 279520 | 25% | 4% | 498 |
7 | GASTRIC ATROPHY | authKW | 275107 | 2% | 39% | 45 |
8 | CHRONIC ATROPHIC GASTRITIS | authKW | 250331 | 2% | 39% | 41 |
9 | GASTRIC CANCER SCREENING | authKW | 238307 | 1% | 77% | 20 |
10 | GASTRITIS | authKW | 231552 | 8% | 9% | 158 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 72350 | 58% | 0% | 1134 |
2 | Oncology | 2101 | 18% | 0% | 364 |
3 | Pathology | 514 | 5% | 0% | 103 |
4 | Medicine, General & Internal | 390 | 8% | 0% | 160 |
5 | Microbiology | 177 | 5% | 0% | 107 |
6 | Medical Laboratory Technology | 114 | 2% | 0% | 30 |
7 | Public, Environmental & Occupational Health | 68 | 4% | 0% | 76 |
8 | Surgery | 66 | 5% | 0% | 108 |
9 | BIOLOGY, MISCELLANEOUS | 36 | 0% | 0% | 2 |
10 | Medicine, Research & Experimental | 36 | 3% | 0% | 56 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC SCREENING ASSESSMENT MANAGEMENT | 110249 | 1% | 65% | 11 |
2 | PATHOL 113 | 46466 | 0% | 50% | 6 |
3 | DIGEST DIS GASTRO | 38721 | 0% | 50% | 5 |
4 | CANC PREVENT MED | 31617 | 0% | 29% | 7 |
5 | AMNCH TCD | 30981 | 0% | 100% | 2 |
6 | KLIN GASROENTEROL HEPATOL INFEKTOL | 30981 | 0% | 100% | 2 |
7 | ENDOSCOPY | 29435 | 4% | 3% | 73 |
8 | GASTROENTEROL | 29407 | 19% | 1% | 382 |
9 | GASTROINTESTINAL PHYSIOL WORKING GRP | 20653 | 0% | 67% | 2 |
10 | IST ONCOL VENETO IOV IRCCS | 20649 | 0% | 33% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HELICOBACTER | 72742 | 4% | 6% | 78 |
2 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 29781 | 7% | 1% | 137 |
3 | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 13645 | 4% | 1% | 70 |
4 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 12423 | 4% | 1% | 72 |
5 | JOURNAL OF GASTROENTEROLOGY | 11777 | 3% | 1% | 52 |
6 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 10465 | 3% | 1% | 67 |
7 | WORLD JOURNAL OF GASTROENTEROLOGY | 8070 | 5% | 1% | 93 |
8 | GUT | 5092 | 3% | 1% | 56 |
9 | GASTRIC CANCER | 5074 | 1% | 2% | 15 |
10 | JOURNAL OF CLINICAL GASTROENTEROLOGY | 4196 | 2% | 1% | 40 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ATROPHIC GASTRITIS | 1369202 | 10% | 46% | 192 | Search ATROPHIC+GASTRITIS | Search ATROPHIC+GASTRITIS |
2 | PEPSINOGEN | 971706 | 8% | 41% | 154 | Search PEPSINOGEN | Search PEPSINOGEN |
3 | INTESTINAL METAPLASIA | 833465 | 11% | 25% | 212 | Search INTESTINAL+METAPLASIA | Search INTESTINAL+METAPLASIA |
4 | HELICOBACTER PYLORI | 695819 | 36% | 6% | 705 | Search HELICOBACTER+PYLORI | Search HELICOBACTER+PYLORI |
5 | PEPSINOGEN I | 298422 | 2% | 57% | 34 | Search PEPSINOGEN+I | Search PEPSINOGEN+I |
6 | GASTRIC CANCER | 279520 | 25% | 4% | 498 | Search GASTRIC+CANCER | Search GASTRIC+CANCER |
7 | GASTRIC ATROPHY | 275107 | 2% | 39% | 45 | Search GASTRIC+ATROPHY | Search GASTRIC+ATROPHY |
8 | CHRONIC ATROPHIC GASTRITIS | 250331 | 2% | 39% | 41 | Search CHRONIC+ATROPHIC+GASTRITIS | Search CHRONIC+ATROPHIC+GASTRITIS |
9 | GASTRIC CANCER SCREENING | 238307 | 1% | 77% | 20 | Search GASTRIC+CANCER+SCREENING | Search GASTRIC+CANCER+SCREENING |
10 | GASTRITIS | 231552 | 8% | 9% | 158 | Search GASTRITIS | Search GASTRITIS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DINIS-RIBEIRO, M , AREIA, M , DE VRIES, AC , MARCOS-PINTO, R , MONTEIRO-SOARES, M , O'CONNOR, A , PEREIRA, C , PIMENTEL-NUNES, P , CORREIA, R , ENSARI, A , ET AL (2012) MANAGEMENT OF PRECANCEROUS CONDITIONS AND LESIONS IN THE STOMACH (MAPS): GUIDELINE FROM THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY (ESGE), EUROPEAN HELICOBACTER STUDY GROUP (EHSG), EUROPEAN SOCIETY OF PATHOLOGY (ESP), AND THE SOCIEDADE PORTUGUESA DE ENDOSCOPIA DIGESTIVA (SPED).ENDOSCOPY. VOL. 44. ISSUE 1. P. 74 -94 | 137 | 58% | 187 |
2 | RISTIMAKI, A , REMBACKEN, B , CARNEIRO, F , KUIPERS, EJ , DINIS-RIBEIRO, M , AREIA, M , DE VRIES, AC , MARCOS-PINTO, R , MONTEIRO-SOARES, M , O'CONNOR, A , ET AL (2012) MANAGEMENT OF PRECANCEROUS CONDITIONS AND LESIONS IN THE STOMACH (MAPS): GUIDELINE FROM THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY (ESGE), EUROPEAN HELICOBACTER STUDY GROUP (EHSG), EUROPEAN SOCIETY OF PATHOLOGY (ESP), AND THE SOCIEDADE PORTUGUESA DE ENDOSCOPIA DIGESTIVA (SPED).VIRCHOWS ARCHIV. VOL. 460. ISSUE 1. P. 19 -46 | 142 | 58% | 20 |
3 | MARQUES-SILVA, L , AREIA, M , ELVAS, L , DINIS-RIBEIRO, M , (2014) PREVALENCE OF GASTRIC PRECANCEROUS CONDITIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS.EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. VOL. 26. ISSUE 4. P. 378-387 | 90 | 83% | 8 |
4 | WECK, MN , BRENNER, H , (2006) PREVALENCE OF CHRONIC ATROPHIC GASTRITIS IN DIFFERENT PARTS OF THE WORLD.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 15. ISSUE 6. P. 1083-1094 | 84 | 75% | 39 |
5 | PASECHNIKOV, V , CHUKOV, S , FEDOROV, E , KIKUSTE, I , LEJA, M , (2014) GASTRIC CANCER: PREVENTION, SCREENING AND EARLY DIAGNOSIS.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 20. ISSUE 38. P. 13842 -13862 | 79 | 51% | 32 |
6 | YOON, H , KIM, N , (2015) DIAGNOSIS AND MANAGEMENT OF HIGH RISK GROUP FOR GASTRIC CANCER.GUT AND LIVER. VOL. 9. ISSUE 1. P. 5 -17 | 65 | 64% | 11 |
7 | WEEK, MN , BRENNER, H , (2008) ASSOCIATION OF HELICOBACTER PYLORI INFECTION WITH CHRONIC ATROPHIC GASTRITIS: META-ANALYSES ACCORDING TO TYPE OF DISEASE DEFINITION.INTERNATIONAL JOURNAL OF CANCER. VOL. 123. ISSUE 4. P. 874-881 | 73 | 77% | 1 |
8 | MIKI, K , (2011) GASTRIC CANCER SCREENING BY COMBINED ASSAY FOR SERUM ANTI-HELICOBACTER PYLORI IGG ANTIBODY AND SERUM PEPSINOGEN LEVELS-"ABC METHOD".PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES. VOL. 87. ISSUE 7. P. 405 -414 | 48 | 89% | 46 |
9 | CHEN, HN , WANG, Z , LI, X , ZHOU, ZG , (2016) HELICOBACTER PYLORI ERADICATION CANNOT REDUCE THE RISK OF GASTRIC CANCER IN PATIENTS WITH INTESTINAL METAPLASIA AND DYSPLASIA: EVIDENCE FROM A META-ANALYSIS.GASTRIC CANCER. VOL. 19. ISSUE 1. P. 166 -175 | 28 | 85% | 11 |
10 | LEUNG, WK , WU, MS , KAKUGAWA, Y , KIM, JJ , YEOH, KG , GOH, KL , WU, KC , WU, DC , SOLLANO, J , KACHINTORN, U , ET AL (2008) SCREENING FOR GASTRIC CANCER IN ASIA: CURRENT EVIDENCE AND PRACTICE.LANCET ONCOLOGY. VOL. 9. ISSUE 3. P. 279 -287 | 41 | 69% | 336 |
Classes with closest relation at Level 1 |